TRIN

TRIN

USD

Trinity Capital Inc. Common Stock

$15.175+0.075 (0.497%)

Real-time Price

Financial services
Asset Management
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$15.100

High

$15.180

Low

$14.970

Volume

2.25M

Company Fundamentals

Market Cap

1.1B

Industry

Asset Management

Country

United States

Trading Stats

Avg Volume

0.78M

Exchange

NMS

Currency

USD

52-Week Range

Low $12.5Current $15.175High $16.82

Related News

PR Newswire

Trinity Capital Inc. Provides Equipment Financing to Bobbie, Bolstering Domestic Infant Formula Industry

Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the funding of equipment and other asset...

View more
Trinity Capital Inc. Provides Equipment Financing to Bobbie, Bolstering Domestic Infant Formula Industry
GlobeNewswire

Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.

$50 million drawn down at closing, with access to up to an additional $80 millionStrengthens Company's financial position; enables initiation of phase 3 clinical trial of CAN-2409 in non-small cell lung cancer

View more
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
PR Newswire

Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer

Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of $130 million in growth...

View more
Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
PR Newswire

Trinity Capital Inc. Expands Life Sciences Vertical with Appointment of Paul D'Agrosa

Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the appointment of Paul D'Agrosa as...

View more
Trinity Capital Inc. Expands Life Sciences Vertical with Appointment of Paul D'Agrosa